Key Takeaways
- Novonesis and Rovensa Next have signed a distribution agreement under which Rovensa Next will commercialise select Novonesis agricultural biosolutions in the United States, beginning with the 2027 growing season.
- The agreement covers a broad product portfolio including Optimize®, NodPro®, Torque®, Ratchet®, BioniQ®, TagTeam®, QuickRoots®, Cell-Tech®, JumpStart®, and Actinovate®, targeting soybeans, corn, pulses, peanuts, and fruit and vegetable crops.
- Rovensa Next will also commercialise Actinovate® for fruit and vegetable crops alongside its existing biocontrol portfolio; Novonesis retains its forage segment, including Optimize® and Nitragin® for alfalfa and clover.
- The North American agricultural biologicals market is projected to reach approximately $5.5 billion by 2027, growing at over 12% CAGR from 2023–2027.
- The United States is now Rovensa Next’s third-largest market by revenue, underpinned by its integration of Oro Agri, Agro-K, and Cosmocel and an established national and regional distributor network.
Novonesis and Rovensa Next Strike US Distribution Deal for Agricultural Biosolutions
Novonesis and Rovensa Next have announced a distribution agreement covering select Novonesis agricultural biosolutions in the United States, with commercial activity set to begin for the 2027 growing season. Under the agreement, Rovensa Next will assume direct commercial responsibility for an expanded product portfolio spanning the full crop cycle — from seed treatment through to post-harvest — across soybeans, corn, pulses, peanuts, and fruit and vegetable crops.
The partnership combines Novonesis’s 130-year track record in agricultural biosolutions with Rovensa Next’s growing US commercial infrastructure, which has been significantly strengthened in recent years through the integration of Oro Agri, Agro-K, and Cosmocel. The United States now represents Rovensa Next’s third-largest market by revenue.
A Full-Cycle Biosolutions Portfolio for US Growers
The combined offering is designed to provide growers with integrated access to biostimulants, biofertilizers, bionutrition, biocontrol, and adjuvants within a single commercial relationship. Rovensa Next will distribute products including Optimize®, NodPro®, Torque®, Ratchet®, BioniQ®, TagTeam®, QuickRoots®, Cell-Tech®, and JumpStart® for soybeans, corn, pulses, and peanuts, as well as Actinovate® for fruit and vegetable applications alongside its existing biocontrol portfolio.
Novonesis will retain direct management of its forage segment, including Optimize® and Nitragin® products for alfalfa and clover crops.
“This partnership with Rovensa Next aligns with our ambition to put more solutions into the hands of retailers and growers. We’re especially excited about accelerating momentum in soybeans with core products like Optimize®, NodPro® and Cell-Tech®XC with its new ProPort Technology, and in pulses where TagTeam® BioniQ® and Cell-Tech® Multi-Pulse have already delivered strong double-digit growth,” said René Garza, Senior Vice President of Planetary Health at Novonesis.
North America: A High-Growth Market for Agricultural Biologicals
The agreement is timed to a period of significant expansion in the US biologicals market. The North American agricultural biologicals segment is projected to reach approximately $5.5 billion by 2027, growing at a compound annual rate of over 12% from 2023–2027, as growers increasingly adopt science-based alternatives that can deliver measurable field performance alongside sustainability benefits.
Rovensa Next has been positioning itself to capitalise on this growth through both acquisition and distribution expansion. The company now operates across specialty crop regions and broad-acre markets in the US, supported by national and regional distributor relationships built through its acquired brands.
“Growers want solutions that are easy to use, proven to work, and deliver an ROI they can count on. The portfolio from this partnership, combined with the existing Rovensa Next portfolio, is built to deliver exactly that — and it happens to be grounded in biosolutions that solve critical crop production problems,” said Chuck Broughton, Head of North America at Rovensa Next.
A New Model for Biologicals Commercialisation
Both companies frame the agreement as an example of an emerging collaboration model in the agricultural biologicals sector, in which biosolutions developers and distribution-focused commercial operators combine complementary strengths rather than competing independently. For Rovensa Next, the arrangement accelerates its stated mission to expand impactful biosolutions across key markets, while Novonesis gains extended reach into US retail and grower channels without building additional direct commercial infrastructure.
2 Comments